Virtus LifeSci Biotech Products ETF
BBP
Market cap $24.8M

62.03 USD

+0.50

0.81%

At close Aug 1, 4:00 PM EDT

1 day

0.81%

5 days

-0.18%

1 month

6.29%

3 months

5.85%

6 months

0.94%

Year to date

2.14%

1 year

0.44%

5 years

34.03%

10 years

71.88%

Funds holding %

of 7,327 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

16% more capital invested

Capital invested by funds: $4.74M [Q4 2024] → $5.49M (+$753K) [Q1 2025]

4.21% more ownership

Funds ownership: 22.56% [Q4 2024] → 26.77% (+4.21%) [Q1 2025]

0% more funds holding

Funds holding: 12 [Q4 2024] → 12 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for BBP.

See Analyst Rankings

Financial journalist opinion

Neutral

Seeking Alpha

2 months ago

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Neutral

Seeking Alpha

5 months ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Positive

Zacks Investment Research

1 year ago

4 Best-Performing Sector ETFs of June

We have highlighted four top-performing ETFs from different sectors that have led the way in June.